Annual EBITDA:
-$94.81M-$6.88M(-7.82%)Summary
- As of today, ALT annual EBITDA is -$94.81 million, with the most recent change of -$6.88 million (-7.82%) on December 31, 2024.
- During the last 3 years, ALT annual EBITDA has risen by +$1.72 million (+1.78%).
- ALT annual EBITDA is now -29246.02% below its all-time high of $325.30 thousand, reached on December 31, 2005.
Performance
ALT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$20.83M+$2.06M(+9.00%)Summary
- As of today, ALT quarterly EBITDA is -$20.83 million, with the most recent change of +$2.06 million (+9.00%) on September 30, 2025.
- Over the past year, ALT quarterly EBITDA has increased by +$3.90 million (+15.76%).
- ALT quarterly EBITDA is now -739.21% below its all-time high of $3.26 million, reached on March 31, 2015.
Performance
ALT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$90.34M+$3.90M(+4.14%)Summary
- As of today, ALT TTM EBITDA is -$90.34 million, with the most recent change of +$3.90 million (+4.14%) on September 30, 2025.
- Over the past year, ALT TTM EBITDA has increased by +$7.07 million (+7.26%).
- ALT TTM EBITDA is now -27660.40% below its all-time high of $327.80 thousand, reached on December 31, 2005.
Performance
ALT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ALT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -7.8% | +15.8% | +7.3% |
| 3Y3 Years | +1.8% | +16.3% | -4.6% |
| 5Y5 Years | -369.6% | -118.1% | -251.2% |
ALT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -12.3% | +1.8% | -12.5% | +21.9% | -8.8% | +12.2% |
| 5Y | 5-Year | -369.6% | +1.8% | -118.1% | +33.7% | -251.2% | +12.2% |
| All-Time | All-Time | >-9999.0% | +1.8% | -739.2% | +33.7% | >-9999.0% | +12.2% |
ALT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$20.83M(+9.0%) | -$90.34M(+4.1%) |
| Jun 2025 | - | -$22.89M(-5.1%) | -$94.24M(+3.9%) |
| Mar 2025 | - | -$21.79M(+12.3%) | -$98.03M(+4.8%) |
| Dec 2024 | -$94.81M(-7.8%) | -$24.83M(-0.4%) | -$102.93M(-5.7%) |
| Sep 2024 | - | -$24.73M(+7.3%) | -$97.42M(-1.7%) |
| Jun 2024 | - | -$26.68M(+0.0%) | -$95.78M(-9.3%) |
| Mar 2024 | - | -$26.69M(-38.2%) | -$87.61M(-5.5%) |
| Dec 2023 | -$87.94M(-4.2%) | -$19.31M(+16.4%) | -$83.03M(+4.6%) |
| Sep 2023 | - | -$23.09M(-24.7%) | -$87.05M(+2.0%) |
| Jun 2023 | - | -$18.51M(+16.3%) | -$88.85M(-0.0%) |
| Mar 2023 | - | -$22.11M(+5.2%) | -$88.81M(-1.1%) |
| Dec 2022 | -$84.41M(+12.6%) | -$23.33M(+6.3%) | -$87.86M(-1.8%) |
| Sep 2022 | - | -$24.89M(-34.7%) | -$86.34M(+7.0%) |
| Jun 2022 | - | -$18.48M(+12.7%) | -$92.87M(-0.8%) |
| Mar 2022 | - | -$21.16M(+3.0%) | -$92.11M(-8.5%) |
| Dec 2021 | -$96.53M(-78.7%) | -$21.81M(+30.6%) | -$84.86M(-15.1%) |
| Sep 2021 | - | -$31.42M(-77.3%) | -$73.71M(-42.2%) |
| Jun 2021 | - | -$17.72M(-27.4%) | -$51.85M(-27.8%) |
| Mar 2021 | - | -$13.91M(-30.3%) | -$40.57M(-26.2%) |
| Dec 2020 | -$54.02M(-167.6%) | -$10.67M(-11.7%) | -$32.15M(-25.0%) |
| Sep 2020 | - | -$9.55M(-48.2%) | -$25.72M(+2.2%) |
| Jun 2020 | - | -$6.45M(-17.5%) | -$26.29M(-15.8%) |
| Mar 2020 | - | -$5.48M(-29.3%) | -$22.71M(-17.1%) |
| Dec 2019 | -$20.19M(+54.9%) | -$4.24M(+58.1%) | -$19.40M(-8.1%) |
| Sep 2019 | - | -$10.12M(-254.4%) | -$17.94M(-52.2%) |
| Jun 2019 | - | -$2.86M(-31.4%) | -$11.79M(+17.6%) |
| Mar 2019 | - | -$2.17M(+21.9%) | -$14.30M(+18.7%) |
| Dec 2018 | -$44.72M(+13.6%) | -$2.79M(+29.9%) | -$17.59M(+2.3%) |
| Sep 2018 | - | -$3.97M(+26.0%) | -$18.01M(+1.9%) |
| Jun 2018 | - | -$5.37M(+1.8%) | -$18.35M(-8.1%) |
| Mar 2018 | - | -$5.46M(-70.4%) | -$16.98M(-6.1%) |
| Dec 2017 | -$51.76M(-374.3%) | -$3.21M(+25.7%) | -$16.01M(-0.5%) |
| Sep 2017 | - | -$4.31M(-8.1%) | -$15.93M(+2.7%) |
| Jun 2017 | - | -$3.99M(+11.1%) | -$16.37M(-17.4%) |
| Mar 2017 | - | -$4.49M(-43.5%) | -$13.95M(-30.7%) |
| Dec 2016 | -$10.91M(-1426.3%) | -$3.13M(+34.2%) | -$10.67M(-26.7%) |
| Sep 2016 | - | -$4.76M(-204.1%) | -$8.42M(-73.2%) |
| Jun 2016 | - | -$1.57M(-28.6%) | -$4.86M(+6.3%) |
| Mar 2016 | - | -$1.22M(-38.1%) | -$5.19M(-625.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$715.00K(+92.9%) | -$880.80K(+26.7%) | -$715.10K(+70.5%) |
| Sep 2015 | - | -$1.20M(+36.5%) | -$2.42M(+53.3%) |
| Jun 2015 | - | -$1.89M(-158.1%) | -$5.18M(-17.2%) |
| Mar 2015 | - | $3.26M(+226.0%) | -$4.42M(+56.0%) |
| Dec 2014 | -$10.04M(+9.6%) | -$2.59M(+34.7%) | -$10.04M(-22.8%) |
| Sep 2014 | - | -$3.96M(-249.2%) | -$8.18M(-10.9%) |
| Jun 2014 | - | -$1.13M(+52.0%) | -$7.37M(+9.9%) |
| Mar 2014 | - | -$2.36M(-226.2%) | -$8.18M(-19.3%) |
| Dec 2013 | -$11.11M(-171.2%) | -$724.10K(+77.0%) | -$6.86M(+8.5%) |
| Sep 2013 | - | -$3.15M(-62.6%) | -$7.49M(-23.7%) |
| Jun 2013 | - | -$1.94M(-86.9%) | -$6.05M(-10.2%) |
| Mar 2013 | - | -$1.04M(+23.6%) | -$5.50M(+7.8%) |
| Dec 2012 | -$4.10M(-24.8%) | -$1.36M(+20.9%) | -$5.96M(-7.0%) |
| Sep 2012 | - | -$1.72M(-24.3%) | -$5.57M(+17.6%) |
| Jun 2012 | - | -$1.38M(+8.2%) | -$6.76M(+19.0%) |
| Mar 2012 | - | -$1.50M(-55.1%) | -$8.35M(+25.9%) |
| Dec 2011 | -$3.28M(+85.9%) | -$970.30K(+66.6%) | -$11.26M(+10.9%) |
| Sep 2011 | - | -$2.91M(+1.9%) | -$12.64M(+1.6%) |
| Jun 2011 | - | -$2.96M(+33.0%) | -$12.84M(+15.3%) |
| Mar 2011 | - | -$4.42M(-88.4%) | -$15.16M(+15.3%) |
| Dec 2010 | -$23.26M(+7.4%) | -$2.35M(+24.4%) | -$17.90M(+16.2%) |
| Sep 2010 | - | -$3.11M(+41.2%) | -$21.36M(+16.3%) |
| Jun 2010 | - | -$5.28M(+26.2%) | -$25.53M(+4.8%) |
| Mar 2010 | - | -$7.16M(-23.2%) | -$26.82M(-7.4%) |
| Dec 2009 | -$25.10M(-37.2%) | -$5.81M(+20.2%) | -$24.98M(-31.4%) |
| Sep 2009 | - | -$7.28M(-10.8%) | -$19.00M(-22.7%) |
| Jun 2009 | - | -$6.57M(-23.5%) | -$15.49M(+48.8%) |
| Mar 2009 | - | -$5.32M(-3333.7%) | -$30.27M(-2.1%) |
| Dec 2008 | -$18.30M(-15.8%) | $164.50K(+104.4%) | -$29.66M(+15.2%) |
| Sep 2008 | - | -$3.77M(+82.4%) | -$34.96M(-1.0%) |
| Jun 2008 | - | -$21.35M(-353.5%) | -$34.62M(-160.9%) |
| Mar 2008 | - | -$4.71M(+8.4%) | -$13.27M(-52.7%) |
| Dec 2007 | -$15.80M(-12.4%) | -$5.14M(-50.0%) | -$8.69M(+49.4%) |
| Sep 2007 | - | -$3.43M(-2654.1%) | -$17.18M(-22.7%) |
| Mar 2007 | - | -$124.40K(+99.1%) | -$14.01M(-0.9%) |
| Dec 2006 | -$14.05M(-4419.1%) | -$13.63M(>-9900.0%) | -$13.88M(>-9900.0%) |
| Sep 2006 | - | -$125.30K(+2.2%) | -$82.10K(-141.1%) |
| Jun 2006 | - | -$128.10K(-174.8%) | $199.70K(-39.1%) |
| Dec 2005 | $325.30K | $171.30K(+9.5%) | $327.80K(+109.5%) |
| Sep 2005 | - | $156.50K | $156.50K |
FAQ
- What is Altimmune, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. annual EBITDA year-on-year change?
- What is Altimmune, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. quarterly EBITDA year-on-year change?
- What is Altimmune, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. TTM EBITDA year-on-year change?
What is Altimmune, Inc. annual EBITDA?
The current annual EBITDA of ALT is -$94.81M
What is the all-time high annual EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high annual EBITDA is $325.30K
What is Altimmune, Inc. annual EBITDA year-on-year change?
Over the past year, ALT annual EBITDA has changed by -$6.88M (-7.82%)
What is Altimmune, Inc. quarterly EBITDA?
The current quarterly EBITDA of ALT is -$20.83M
What is the all-time high quarterly EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high quarterly EBITDA is $3.26M
What is Altimmune, Inc. quarterly EBITDA year-on-year change?
Over the past year, ALT quarterly EBITDA has changed by +$3.90M (+15.76%)
What is Altimmune, Inc. TTM EBITDA?
The current TTM EBITDA of ALT is -$90.34M
What is the all-time high TTM EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high TTM EBITDA is $327.80K
What is Altimmune, Inc. TTM EBITDA year-on-year change?
Over the past year, ALT TTM EBITDA has changed by +$7.07M (+7.26%)